Altin Biosciences

Curated by Signal

Developer of drugs for the treatment of uterine fibroids

Life Sciences Technologyaltinbiosciences.com

Overview

Developer of drugs for the treatment of uterine fibroids. The company focuses on the development of botanical drug candidates including a non-hormonal ABC-105 and ABC-205 for the treatment of uterine fibroids.

Key facts

Founded: 2022
Headquarters: Emeryville, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Nova Diabetes Care
Develops blood glucose testing analyzers
Life Sciences TechnologyBillerica, United States
Electrical Geodesics
Non-invasive neurodiagnostic imaging products are built upon a dense array of EEG technology platforms
Life Sciences TechnologyEugene, United States
Green Leaf Lab
Bioanalytical and testing services for the cannabis industry
Life Sciences TechnologyPortland, United States

About Altin Biosciences

What does Altin Biosciences do?

Developer of drugs for the treatment of uterine fibroids.

Where is Altin Biosciences headquartered?

Altin Biosciences is headquartered in Emeryville, United States.

When was Altin Biosciences founded?

Altin Biosciences was founded in 2022.

Which sector is Altin Biosciences in?

Altin Biosciences operates in Life Sciences Technology.

Who are Altin Biosciences's competitors?

Companies similar to Altin Biosciences include Nova Diabetes Care, Electrical Geodesics, and Green Leaf Lab.